LIVN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
LIVN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-10-31), LivaNova's share price is $51.54. LivaNova's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was $2.90. Hence, LivaNova's Price-to-Operating-Cash-Flow Ratio for today is 17.77.
The historical rank and industry rank for LivaNova's Price-to-Operating-Cash-Flow or its related term are showing as below:
During the past 13 years, LivaNova's highest Price-to-Operating-Cash-Flow Ratio was 91.34. The lowest was 16.00. And the median was 35.48.
LivaNova's Cash Flow from Operations per share for the three months ended in Sep. 2024 was $0.93. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was $2.90.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of LivaNova was 115.60% per year.
During the past 13 years, LivaNova's highest 3-Year average Operating Cash Flow per Share Growth Rate was 47.30% per year. The lowest was -18.10% per year. And the median was 1.30% per year.
The historical data trend for LivaNova's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LivaNova Annual Data | |||||||||||||||||||||
Trend | Apr14 | Apr15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Price-to-Operating-Cash-Flow | Get a 7-Day Free Trial | - | - | 43.18 | 42.46 | 37.44 |
LivaNova Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Price-to-Operating-Cash-Flow | Get a 7-Day Free Trial | 71.56 | 37.44 | 47.45 | 23.78 | - |
For the Medical Devices subindustry, LivaNova's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, LivaNova's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where LivaNova's Price-to-Operating-Cash-Flow falls into.
LivaNova's Price-to-Operating-Cash-Flow ratio for today is calculated as
Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
= | 51.54 | / | 2.901 | |
= | 17.77 |
LivaNova's Share Price of today is $51.54.
LivaNova's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.90.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Price-to-Operating-Cash-Flow Ratio | = | Market Cap | / | Cash Flow from Operations |
Thank you for viewing the detailed overview of LivaNova's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Francesco Bianchi | director | C/O LIVANOVA PLC, 5 MERCHANT SQUARE, LONDON X0 W2 1AY |
Daniel Jeffrey Moore | director | 100 CYBERONICS BVLD, HOUSTON TX 77058 |
James Christopher Barry | director | 7475 LUSK BLVD, SAN DIEGO CA 92121 |
Damien Mcdonald | officer: COO | 5 MERCHANT SQUARE, NORTH WHARF ROAD, LONDON X0 W21AY |
Michael Damon Hutchinson | officer: Chief Legal Officer | 2825 AIRVIEW BLVD, KALAMAZOO MI 49002 |
Brooke Story | director | C/O SIGILON THERAPEUTICS, INC., 100 BINNEY STREET, SUITE 600, CAMBRIDGE MA 02142 |
Peter M Wilver | director | |
Alfred J Novak | director | 325 NE 6TH ST, BOCA RATON FL 33432 |
William A Kozy | director | C/O BECTON DICKERSON & CO, 1 BECTON DR, FRANKLIN LAKES NJ 07417 |
Marco Dolci | officer: SVP Global Operations, R&D | VIA BENIGNO CRESPI 17, MILAN L6 20159 |
Todd C Schermerhorn | director | C/O C.R BARD INC, 730 CENTRAL AVE, MURRAY HILL NJ 07974 |
Alex Shvartsburg | officer: Interim CFO | 20 EASTBOURNE TERRACE, LONDON X0 W26LG |
Roy Khoury | officer: President, International | 5 MERCHANT SQUARE, NORTH WHARF ROAD, LONDON X0 W21AY |
Thad Allen Huston | officer: Chief Financial Officer | 941 BLOOMFIELD ST, HOBOKEN NJ 07030 |
Seng Stacy Enxing | director | C/O HILL-ROM HOLDINGS, INC., SUITE 4100 180 NORTH STETSON AVENUE, CHICAGO IL 60601 |
From GuruFocus
By Business Wire • 04-30-2024
By Business Wire • 03-20-2024
By Business Wire • 03-04-2024
By GuruFocus Research • 09-17-2024
By PRNewswire • 07-02-2024
By GuruFocus Research • 03-20-2024
By GuruFocus Research • 09-14-2024
By Marketwired • 07-20-2024
By Business Wire • 06-06-2024
By GuruFocus Research • 05-01-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.